Liberum Health Ltd Porous Polymeric Drug Delivery Device
Summary
Liberum Health Ltd filed USPTO patent application US20260097190A1 for a porous polymeric drug delivery device that modulates drug release through charged encapsulation. The application covers the device, its method of manufacture, a charged drug delivery device with encapsulated drug, and a kit-of-parts comprising the device and drug for encapsulation.
What changed
Liberum Health Ltd filed USPTO patent application US20260097190A1 covering a porous polymeric drug delivery device designed to modulate drug delivery. The invention includes a charged drug delivery device wherein the drug is encapsulated by the porous polymeric material, along with the method of manufacture and a kit-of-parts comprising the device and drug for encapsulation.
Pharmaceutical companies and medical device manufacturers should monitor this patent publication as it may affect freedom-to-operate considerations for drug encapsulation technologies. The porous polymeric approach represents a specific drug delivery modulation technique that could be relevant to controlled-release formulations.
What to do next
- Monitor for updates on patent prosecution status
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
DRUG DELIVERY DEVICE
Application US20260097190A1 Kind: A1 Apr 09, 2026
Assignee
LIBERUM HEALTH LTD
Inventors
Alexander SEIFALIAN, Amelia SEIFALIAN, Chayma NOUAJAA, Alena VDOVCHENKO, Karolina AFORS, Hana SALUSSOLIA
Abstract
A drug delivery device including a porous polymeric material for modulating the delivery of the drug, and a method of manufacture thereof includes: a charged drug delivery device, and a method of manufacture thereof, wherein the charged drug delivery device includes the drug delivery device and a drug, wherein the drug is encapsulated by the drug delivery device, the charged drug delivery device for use in administering a drug, and a kit-of-parts comprising the drug delivery device and a drug for encapsulation in the drug delivery device.
CPC Classifications
A61M 31/002 A61M 2205/0244 A61M 2207/00 A61M 2210/1475
Filing Date
2023-10-16
Application No.
19120894
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.